Akorn Inc (NASDAQ:AKRX) Just Reported Decreased Shorts

April 17, 2018 - By Adrian Erickson

The stock of Akorn Inc (NASDAQ:AKRX) registered a decrease of 3.75% in short interest. AKRX’s total short interest was 10.54 million shares in April as published by FINRA. Its down 3.75% from 10.95M shares, reported previously. With 1.13 million shares average volume, it will take short sellers 9 days to cover their AKRX’s short positions. The short interest to Akorn Inc’s float is 11.29%.

The stock increased 1.50% or $0.28 during the last trading session, reaching $18.97. About 476,361 shares traded. Akorn, Inc. (NASDAQ:AKRX) has declined 20.35% since April 17, 2017 and is downtrending. It has underperformed by 31.90% the S&P500.

Akorn, Inc., a specialty generic pharmaceutical company, develops, makes, and markets specialized generic and branded pharmaceuticals, over-the-counter drug products, and animal health products in the United States and internationally. The company has market cap of $2.38 billion. The firm operates in two divisions, Prescription Pharmaceuticals and Consumer Health. It currently has negative earnings. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics.

Akorn, Inc. (NASDAQ:AKRX) Ratings Coverage

Among 6 analysts covering Akorn (NASDAQ:AKRX), 0 have Buy rating, 0 Sell and 6 Hold. Therefore 0 are positive. Akorn had 7 analyst reports since October 20, 2017 according to SRatingsIntel. As per Friday, October 27, the company rating was maintained by Jefferies. The company was maintained on Thursday, March 15 by Susquehanna. RBC Capital Markets maintained the stock with “Hold” rating in Sunday, November 5 report. RBC Capital Markets maintained it with “Hold” rating and $2500 target in Thursday, March 29 report. Piper Jaffray maintained Akorn, Inc. (NASDAQ:AKRX) on Friday, October 20 with “Hold” rating. William Blair maintained the shares of AKRX in report on Wednesday, February 28 with “Hold” rating.

Akorn, Inc. (NASDAQ:AKRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.